Nederlandse Medicijnen Verificatie Organisatie

What Nederlandse Medicijnen Verificatie Organisatie does

Nederlandse Medicijnen Verificatie Organisatie (NMVO) is a Dutch non-profit foundation (stichting zonder winstoogmerk) founded in August 2016 to operate the National Medicines Verification System (NMVS), the national infrastructure mandated by the EU Falsified Medicines Directive (FMD) that came into force on 9 February 2019. The organization serves Marketing Authorization Holders (MAHs), pharmaceutical wholesalers, and approximately 1,900 Dutch pharmacies (community pharmacies, hospital pharmacies, and pharmacy-holding general practitioners), requiring each to connect to the NMVS and perform mandatory verification and decommissioning scans on prescription medicine packages to prevent falsified medicines from reaching patients.

The core product is the NMVS, a GxP-compliant and ISO 27001-certified database that tracks every prescription medicine package via a unique 2D code, with PKI-based certificate authentication, a pseudoniem (subuser-ID) system for certain pharmacy connections, and connectivity to the European Medicines Verification System (EMVS) via the European Medicines Verification Organisation (EMVO). The system uses IF-PHARMACY V5 endpoints and processes over 1.2 million package scans per day through Dutch pharmacies. Supporting the core platform, NMVO operates an Arvato-hosted SWS-Portal for software supplier onboarding and baseline testing, an NMVS PKI-Portal for certificate management, a web-based Scanner-Tool for pharmacy 2D scanner configuration, and a Persoonlijke Rapportage monthly alert reporting service.

NMVO's revenue model is a closed-loop annual fee charged exclusively to MAHs — €8,200 per MAH per year for 2026, reduced from €10,000 through 2023 following cost savings — invoiced once per year in the last quarter, with any year-end surplus refunded pro-rata to fee payers. Discounts of €5,000 are available for small MAHs or late registrants. Pharmacies, wholesalers, and pharmacy-holding GPs are not charged for NMVS usage. Governance is provided by four industry associations (Bogin, VIG, KNMP, and BG Pharma) that constitute the foundation's board. The seven-person staff is led by Director Dorien Verbree and operates from a single office at Pr. Margrietplantsoen 33, Den Haag.

Name

Nederlandse Medicijnen Verificatie Organisatie

Legal name

Stichting Nederlandse Medicijnen Verificatie Organisatie

Website

https://nmvo.nl

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

NMVO is a Dutch non-profit foundation operating the National Medicines Verification System (NMVS), mandated under EU FMD law to verify unique codes on every prescription medicine package as it moves from manufacturers through wholesalers to approximately 1,900 Dutch pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Verification Systems

akta.pro primary industry

Drug Regulators (Human Pharmaceuticals) (HLAJADAA)

Keywords

• Medicines verification system
• Pharmaceutical supply chain
• Falsified medicines directive
• Medicine package tracking
• Pharmaceutical compliance platform

Headquarters

HQ city

Den Haag

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Annual MAH Fee: NMVO is a non-profit foundation (stichting zonder winstoogmerk). Revenue is generated solely through annual fees charged to Marketing Authorization Holders (MAHs / fabrikanten/registratiehouders). Fees are invoiced once per year in the last quarter. Any surplus at year-end is refunded pro rata to fee payers. Fee for 2026 is €8,200 per year per MAH.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

NMVO operates the Nederlands Medicijnen Verificatie Systeem (NMVS), a national database mandated by the EU Falsified Medicines Directive (FMD) that tracks unique codes on every prescription medicine package. Manufacturers (MAHs) upload codes; pharmacists and wholesalers scan and verify/decommission packages against the system, with every package movement logged in a full audit trail. The organization charges MAHs an annual fee of €8,200 (2026 rate) to access the system, while pharmacies and wholesalers connect free of charge.

Product overview

NMVO operates a single unified system — the Nederlands Medicijnen Verificatie Systeem (NMVS) — which is the national medicines verification database mandated by the EU Falsified Medicines Directive (FMD). The NMVS tracks every prescription medicine package via a unique 2D code, enabling verification scans by wholesalers and decommissioning scans by pharmacies before dispensing. The core NMVS platform is complemented by a PKI-portal for certificate management, a Scanner-Tool for scanner testing and configuration, an Arvato-operated SWS-portal for software supplier onboarding and testing, and an automated monthly alert reporting service (Persoonlijke Rapportage) for pharmacies. Software suppliers (such as Pharmapartners via NMVS_Dispatcher, Chipsoft HiX, SmartMed, and others) build and maintain approved connection modules that integrate their AIS/HIS/ZIS systems with the NMVS endpoints.

Differentiator

Problem solved

Functional benefit

Products and services

• NMVS (Nederlands Medicijnen Verificatie Systeem) The National Medicines Verification System (NMVS) is the core database operated by NMVO that tracks individual medicine packages via unique 2D codes and anti-tamper mechanisms, enabling Marketing Authorization Holders (MAHs), wholesalers, and pharmacies to perform verification and decommissioning scans mandated by the EU Falsified Medicines Directive (FMD). The system generates alerts when scans indicate potential falsification, maintains a full audit trail of all package movements, and communicates with the European Medicines Verification System (EMVS) via the EU hub.
• Baseline Test for Software Suppliers A standardized testing procedure administered by NMVO that software suppliers must pass to demonstrate their connection module correctly communicates with the NMVS. Successful completion grants access to the NMVS production environment. Required for all 28+ approved software suppliers.
• SWS-Portal (Arvato) A developer portal operated by Arvato (the NMVS builder) where approved software suppliers access technical documentation, execute sample transactions, create test packages, and perform baseline testing for NMVS connection. Technical support provided by Arvato at [email protected].
• NMVS PKI-Portal A certificate management portal used by NMVS end-users (pharmacies and wholesalers) to download and manage their NMVS authentication certificates. Users authenticate with username, password, and TAN-code to download SHA-1 formatted certificates.
• NMVO Scanner-Tool (Scanner Test-Tool & Scanner Configuration-Tool) A set of web-based tools provided by NMVO for pharmacies to test whether 2D barcode scanners are correctly configured for FMD scanning and to reconfigure scanners to resolve common issues such as CapsLock sensitivity and inverse-code scanning.
• Persoonlijke Rapportage (Monthly Alert Report) An automated monthly report sent to pharmacy operators detailing alerts generated at their location, including probable causes and recommended remediation actions to reduce unnecessary alerts.
• Alert Investigation Support NMVO investigates all alerts and assists MAHs, pharmacies, and wholesalers in determining whether an alert indicates a genuine falsification or has a technical/logistical cause such as scanner misconfiguration, delayed uploads by manufacturers, or double decommissioning. Alerts are reported to IGJ (Dutch Healthcare and Youth Inspectorate) as required.

Quantifiable outcome

• Netherlands achieved 95% scan rate in 2025, up from 79% in 2023 — one of the best-performing countries in Europe for medicine verification
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration17 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core.

• European Medicines Verification Organisation (EMVO)coreTechnology or IntegrationEMVO manages the European Medicines Verification System (EMVS), the central EU database hub. NMVO works closely with EMVO to ensure seamless, safe, and efficient exchange of information required by FMD legislation between the NMVS and EMVS. All MAHs must connect to the EMVS via EMVO.
• Arvato SystemscoreTechnology or IntegrationArvato Systems is the developer and operator of the NMVS technical infrastructure. They also provide the SWS Portal used by software suppliers for testing and baseline testing of their NMVS connection modules. Technical support for the SWS Portal is handled by Arvato via [email protected].
• KNMP (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie)coreStrategic or Co-development PartnerKNMP is the Dutch pharmacy association and a member of the NMVO board. NMVO and KNMP jointly developed working instructions for pharmacies on FMD implementation. KNMP director Eric Janson publicly praised Dutch pharmacies for achieving 95% scan rate.
• Bogin (Biosimilars en Generieke Geneesmiddelenindustrie Nederland)coreStrategic or Co-development PartnerBogin is the Dutch association for biosimilar and generic medicines industry and a member of the NMVO board. NMVO board chairman Jean Hermans is also a board member of Bogin.
• VIG (Vereniging Innovatieve Geneesmiddelen)coreStrategic or Co-development PartnerVIG is the Dutch association for innovative medicines and a member of the NMVO board. Carla Vos, Director of VIG, serves as Treasurer on the NMVO board.
• BG Pharma (Branchevereniging Volgesorteerde Farmaceutische Groothandelaren)coreStrategic or Co-development PartnerBG Pharma is the association for sorted pharmaceutical wholesalers and a member of the NMVO board. Geo Aldershof, Director of BG Pharma, serves as Secretary on the NMVO board.
• Inspectie voor Gezondheidszorg en Jeugd (IGJ)coreOthersIGJ is the Dutch Healthcare and Youth Inspectorate, the regulatory body overseeing FMD compliance. IGJ receives alerts from NMVO, conducts inspections, monitors scan rates, and can take enforcement action. NMVO is legally required to report to IGJ.
• Approved NMVS Software Suppliers (28+ listed)coreTechnology or Integration28+ software suppliers including Arvato Systems, Chipsoft HiX, Pharmapartners NMVS_Dispatcher, Sanday APRO, SmartMed, BD Pyxis, and others have passed NMVO baseline testing and are approved to provide NMVS-connected software to pharmacies and wholesalers in the Netherlands.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• European Medicines Verification Organisation (EMVO): EMVO operates the central EU hub (EMVS) that connects all national medicines verification systems, including NMVO's NMVS. Most directly comparable as the supra-national counterpart to NMVO, sharing the same regulatory mandate, technology architecture, and FMD-driven mission.
• SecurPharm e.V. Germany's national medicines verification organization operating under the same EU FMD framework. Directly comparable as a national FMD-mandated verification operator with MAH fee funding and pharmacy/wholesaler onboarding responsibilities.
• France MVO: France's national medicines verification organization, operating the French NMVS under the EU FMD. Closely comparable in mandate, fee-based funding model, and stakeholder mix (MAHs, wholesalers, pharmacies).
• SEVeM (Sistema Español de Verificación de Medicamentos): Spain's national medicines verification organization, fulfilling the same EU FMD verification mandate as NMVO for the Spanish market. Directly comparable in operating model, regulatory role, and end-user constituencies.
• Italian Medicines Verification System (managed by IMA/Italian NMVSO): Italy's national medicines verification organization operating under the EU FMD framework. Closely comparable in mandate, scale considerations (large national pharmaceutical market), and MAH fee funding model.
• BE-MVO (Belgian Medicines Verification Organisation): Belgium's national medicines verification organization, also serving a small-to-mid EU market under the FMD mandate. Directly comparable to NMVO in regulatory role, stakeholder mix, and operational scope.

Others

• SolidSoft Reply: Technology provider that has built and operates the national medicines verification systems for several EU member states under the EMVS blueprint. Comparable as the technology vendor counterpart to NMVO's relationship with Arvato Systems.
• Arvato Systems: Technology partner that developed and operates the NMVS core platform and SWS-portal for NMVO. Adjacent peer — same technology underpins other national verification systems — but not a direct competitor.
• KNMP (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie): Royal Dutch Pharmacists Association and NMVO board member. Comparable as a Dutch pharmacy-sector stakeholder, but not a verification operator; serves as an industry-association counterpart.

Emerging players

• Aegate Holdings / Aegate-Melvin (authentication services): Provider of medicines authentication and verification services in select European markets. Comparable as a participant in the broader medicines verification ecosystem, though operating commercially rather than as a non-profit national mandate holder.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/stichting-nmvo

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nederlandse Medicijnen Verificatie Organisatie